FDA Inspection
OrBion Pharmaceuticals Private LimitedOrBion Pharmaceuticals Private Limited – FDA Inspection, May 31, 2019
Record Details
This FDA Inspection record concerns OrBion Pharmaceuticals Private Limited, with an inspection on May 31, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 6435cb4b-cafe-4dce-89f6-11d07f6e1b87
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1091278
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
5- 21 CFR 211.46(b)Equipment for Environmental Control
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.113(a)Procedures for non-sterile drug products
- 21 CFR 211.165(e)Test methods
- 21 CFR 211.110(a)(1)Tablet or capsule weight variation
Full citation text and observation details available on the Dashboard.
Other FDA inspections of OrBion Pharmaceuticals Private Limited
7| Date | Classification | Office | Project area |
|---|---|---|---|
| October 27, 2025 | OAI | Generic Drug Evaluation | |
| May 10, 2024 | Not classified | Office of Inspections and Investigations | |
| September 8, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 15, 2016 | Not classified | Office of Inspections and Investigations | |
| June 3, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for OrBion Pharmaceuticals Private Limited
- FDA Inspection 1289382 - 2025-10-27
- FDA Inspection 1240651 - 2024-05-10
- FDA Inspection 1217144 - 2023-09-08
- FDA Inspection 1001296 - 2016-12-15
- FDA Inspection 934390 - 2015-06-03
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.